DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
86.98
+1.65 (1.93%)
At close: May 28, 2025, 4:00 PM
86.96
-0.02 (-0.02%)
After-hours: May 28, 2025, 5:30 PM EDT

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of $34.11 billion. The enterprise value is $33.92 billion.

Market Cap 34.11B
Enterprise Value 33.92B

Important Dates

The last earnings date was Thursday, May 1, 2025, after market close.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

DexCom has 392.11 million shares outstanding. The number of shares has decreased by -3.45% in one year.

Current Share Class 392.11M
Shares Outstanding 392.11M
Shares Change (YoY) -3.45%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) 0.34%
Owned by Institutions (%) 94.45%
Float 389.33M

Valuation Ratios

The trailing PE ratio is 65.29 and the forward PE ratio is 39.64. DexCom's PEG ratio is 1.76.

PE Ratio 65.29
Forward PE 39.64
PS Ratio 8.10
Forward PS 6.99
PB Ratio 14.76
P/TBV Ratio 15.85
P/FCF Ratio 59.18
P/OCF Ratio 35.31
PEG Ratio 1.76
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.55, with an EV/FCF ratio of 58.98.

EV / Earnings 63.39
EV / Sales 8.18
EV / EBITDA 39.55
EV / EBIT 53.63
EV / FCF 58.98

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 1.14.

Current Ratio 1.50
Quick Ratio 1.27
Debt / Equity 1.14
Debt / EBITDA 2.89
Debt / FCF 4.49
Interest Coverage 33.12

Financial Efficiency

Return on equity (ROE) is 23.72% and return on invested capital (ROIC) is 8.16%.

Return on Equity (ROE) 23.72%
Return on Assets (ROA) 5.98%
Return on Invested Capital (ROIC) 8.16%
Return on Capital Employed (ROCE) 17.03%
Revenue Per Employee $402,718
Profits Per Employee $51,961
Employee Count 10,300
Asset Turnover 0.63
Inventory Turnover 2.90

Taxes

In the past 12 months, DexCom has paid $195.60 million in taxes.

Income Tax 195.60M
Effective Tax Rate 26.77%

Stock Price Statistics

The stock price has decreased by -31.63% in the last 52 weeks. The beta is 1.43, so DexCom's price volatility has been higher than the market average.

Beta (5Y) 1.43
52-Week Price Change -31.63%
50-Day Moving Average 74.47
200-Day Moving Average 75.88
Relative Strength Index (RSI) 66.91
Average Volume (20 Days) 3,990,570

Short Selling Information

The latest short interest is 11.41 million, so 2.91% of the outstanding shares have been sold short.

Short Interest 11.41M
Short Previous Month 10.61M
Short % of Shares Out 2.91%
Short % of Float 2.93%
Short Ratio (days to cover) 2.47

Income Statement

In the last 12 months, DexCom had revenue of $4.15 billion and earned $535.20 million in profits. Earnings per share was $1.33.

Revenue 4.15B
Gross Profit 2.47B
Operating Income 632.60M
Pretax Income 806.90M
Net Income 535.20M
EBITDA 857.80M
EBIT 632.60M
Earnings Per Share (EPS) $1.33
Full Income Statement

Balance Sheet

The company has $2.70 billion in cash and $2.58 billion in debt, giving a net cash position of $118.20 million or $0.30 per share.

Cash & Cash Equivalents 2.70B
Total Debt 2.58B
Net Cash 118.20M
Net Cash Per Share $0.30
Equity (Book Value) 2.27B
Book Value Per Share 5.78
Working Capital 1.52B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $964.10 million and capital expenditures -$388.90 million, giving a free cash flow of $575.20 million.

Operating Cash Flow 964.10M
Capital Expenditures -388.90M
Free Cash Flow 575.20M
FCF Per Share $1.47
Full Cash Flow Statement

Margins

Gross margin is 59.43%, with operating and profit margins of 15.25% and 12.90%.

Gross Margin 59.43%
Operating Margin 15.25%
Pretax Margin 17.62%
Profit Margin 12.90%
EBITDA Margin 20.68%
EBIT Margin 15.25%
FCF Margin 13.87%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 3.45%
Shareholder Yield 3.45%
Earnings Yield 1.57%
FCF Yield 1.69%
Dividend Details

Analyst Forecast

The average price target for DexCom is $98.00, which is 12.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target $98.00
Price Target Difference 12.67%
Analyst Consensus Strong Buy
Analyst Count 18
Revenue Growth Forecast (5Y) 15.02%
EPS Growth Forecast (5Y) 23.98%
Stock Forecasts

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Jun 13, 2022
Split Type Forward
Split Ratio 4:1

Scores

DexCom has an Altman Z-Score of 6.35 and a Piotroski F-Score of 5.

Altman Z-Score 6.35
Piotroski F-Score 5